11:40 AM EDT, 07/21/2025 (MT Newswires) -- Merck ( MRK ) said Monday that Health Canada has approved Keytruda in combination with chemoradiotherapy to treat adult patients with FIGO 2014 Stage III-IVA cervical cancer.
FIGO refers to International Federation of Gynecology and Obstetrics.
The drugmaker said the approval followed a statistically significant improvement in overall survival and progression-free survival in patients with Stage III-IVa in a late-stage trial.
Price: 79.19, Change: -0.77, Percent Change: -0.96